Download PDF
1 / Pages

Other users also viewed these articles

Ceftolozane/tazobactam for the treatment of Pseudomonas aeruginosa infections: A multicenter case series analysis Inês Leonor Leitão; Carla Mimoso Santos; Paulo André; Sara Lino; Marcos Lemos; Filipe Froes;
Enferm Infecc Microbiol Clin. 2023;41:454-61
Validation of MALDI-TOF for the early detection of the ST175 high-risk clone of Pseudomonas aeruginosa in clinical isolates belonging to a Spanish nationwide multicenter study Xavier Mulet; Marta Fernández-Esgueva; Cristina Norte; Laura Zamorano; Ester del Barrio-Tofiño; Antonio Oliver;
Enferm Infecc Microbiol Clin. 2021;39:279-82
Characterization of AmpC ß-lactamase mutations of extensively drug-resistant Pseudomonas aeruginosa isolates that develop resistance to ceftolozane/tazobactam during therapy Marta Fernández-Esgueva; Ana Isabel López-Calleja; Xavier Mulet; Pablo A. Fraile-Ribot; Gabriel Cabot; Rafael Huarte; Antonio Rezusta; Antonio Oliver;
Enferm Infecc Microbiol Clin. 2020;38:474-8